Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ER alpha/NR3A1 Antibody (OTI2D3), DyLight 680, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP270688FR

Catalog No. NBP270688FR


Add to Cart

Description

Description

ER alpha/NR3A1 Monoclonal specifically detects ER alpha/NR3A1 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry.
Specifications

Specifications

ER alpha/NR3A1
Monoclonal
DyLight 680
PBS with 0.05% Sodium Azide
ESR1
Recombinant protein fragment corresponding to amino acids 1-310 of human ER alpha/NR3A1 (NP_000116) produced in E.coli.
0.1 mL
Primary
Human, Mouse, Rat
IgG1
Western Blot, Immunohistochemistry
OTI2D3
Western Blot, Immunohistochemistry
ER, ER alpha, Era, ER-alpha, ESRESRA, Estradiol receptor, estrogen receptor, estrogen receptor 1, estrogen receptor alpha, estrogen receptor alpha delta 3*4,56,7*/819-2 isoform, estrogen receptor alpha delta 4 +49 isoform, estrogen receptor alpha delta 4*5,6,7*/654 isoform, NR3A1DKFZp686N23123, Nuclear receptor subfamily 3 group A member 1
Mouse
Affinity Purified
Angiogenesis, Breast Cancer, Cancer, Cell Biology, Cell Cycle and Replication, Dendritic Cell Markers, GPCR, Neuroscience, Phospho Specific, Signal Transduction, Transcription Factors and Regulators
2099.0
Store at 4°C in the dark.
Recommendations

Recommendations

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit